NCT05929066: A Study of Retatrutide (LY3437943) in Participants Who Have Obesity or Overweight
- State
- Completed
- Phase
- Phase 3
- People
- 2,335 taking part
- Started
- 10 Jul 2023
- Primary completion
- 6 Apr 2026
- Arms
- Retatrutide Dose 1, Retatrutide Dose 2, Retatrutide Dose 3, Retatrutide Extension Period
- Results
- None posted
- 3 Jul 2023: Trial registered
- 10 Jul 2023: Trial started
- 30 Apr 2026: Trial completed